BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17320759)

  • 1. Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate.
    Vissers MC; Gunningham SP; Morrison MJ; Dachs GU; Currie MJ
    Free Radic Biol Med; 2007 Mar; 42(6):765-72. PubMed ID: 17320759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer.
    Kuiper C; Molenaar IG; Dachs GU; Currie MJ; Sykes PH; Vissers MC
    Cancer Res; 2010 Jul; 70(14):5749-58. PubMed ID: 20570889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response.
    Kuiper C; Dachs GU; Currie MJ; Vissers MC
    Free Radic Biol Med; 2014 Apr; 69():308-17. PubMed ID: 24495550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo(-/-) mice.
    Campbell EJ; Vissers MC; Bozonet S; Dyer A; Robinson BA; Dachs GU
    Cancer Med; 2015 Feb; 4(2):303-14. PubMed ID: 25354695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor -1 alpha activity and reduce malignant potential in human melanoma.
    Fischer AP; Miles SL
    Biomed Pharmacother; 2017 Feb; 86():502-513. PubMed ID: 28012930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells.
    Melstrom LG; Salabat MR; Ding XZ; Strouch MJ; Grippo PJ; Mirzoeva S; Pelling JC; Bentrem DJ
    J Surg Res; 2011 May; 167(2):173-81. PubMed ID: 21227456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate.
    Jones DT; Trowbridge IS; Harris AL
    Cancer Res; 2006 Mar; 66(5):2749-56. PubMed ID: 16510596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells.
    Tsuzuki T; Okada H; Cho H; Tsuji S; Nishigaki A; Yasuda K; Kanzaki H
    Hum Reprod; 2012 Feb; 27(2):523-30. PubMed ID: 22128293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
    Xia T; Cheng H; Zhu Y
    Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells.
    Knowles HJ; Raval RR; Harris AL; Ratcliffe PJ
    Cancer Res; 2003 Apr; 63(8):1764-8. PubMed ID: 12702559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glucose transporter protein-1 and vascular endothelial growth factor by hypoxia inducible factor 1α under hypoxic conditions in Hep-2 human cells.
    Xu O; Li X; Qu Y; Liu S; An J; Wang M; Sun Q; Zhang W; Lu X; Pi L; Zhang M; Shen Y
    Mol Med Rep; 2012 Dec; 6(6):1418-22. PubMed ID: 22971798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ROS-induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF-1alpha in the NCI60 cancer cell lines.
    Sinnberg T; Noor S; Venturelli S; Berger A; Schuler P; Garbe C; Busch C
    J Cell Mol Med; 2014 Mar; 18(3):530-41. PubMed ID: 24330097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-α upregulates HIF-1α expression in pterygium fibroblasts and enhances their susceptibility to VEGF independent of hypoxia.
    Kim KW; Lee SJ; Kim JC
    Exp Eye Res; 2017 Nov; 164():74-81. PubMed ID: 28803935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity.
    Jeong S; Park H; Hong S; Yum S; Kim W; Jung Y
    Eur J Pharmacol; 2015 Jan; 747():114-22. PubMed ID: 25483211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels.
    Campbell EJ; Dachs GU; Morrin HR; Davey VC; Robinson BA; Vissers MCM
    BMC Cancer; 2019 Apr; 19(1):307. PubMed ID: 30943919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.
    Palayoor ST; Tofilon PJ; Coleman CN
    Clin Cancer Res; 2003 Aug; 9(8):3150-7. PubMed ID: 12912967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
    Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
    BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic ascorbate (P-AscH
    Wilkes JG; O'Leary BR; Du J; Klinger AR; Sibenaller ZA; Doskey CM; Gibson-Corley KN; Alexander MS; Tsai S; Buettner GR; Cullen JJ
    Clin Exp Metastasis; 2018 Feb; 35(1-2):37-51. PubMed ID: 29396728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
    Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
    Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.